lactic acid has been researched along with hirudin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Groth, T; Romaniuk, P; Seifert, B | 1 |
| Alt, E; Beilharz, C; Erhardt, W; Fliedner, T; Haehnel, I; Preter, D; Prietzel, K; Schömig, A; Stemberger, A | 1 |
| Derugin, N; Hashi, CK; Janairo, RR; Lee, R; Li, S; Lotz, J; Schultz, D | 1 |
| Horner, PJ; Kim, TH; Mount, CW; Pun, SH; Sellers, DL | 1 |
4 other study(ies) available for lactic acid and hirudin
| Article | Year |
|---|---|
Covalent immobilization of hirudin improves the haemocompatibility of polylactide-polyglycolide in vitro.
Topics: Antithrombins; Biocompatible Materials; Blood Coagulation; Hirudins; Humans; Lactic Acid; Microscopy, Fluorescence; P-Selectin; Platelet Activation; Platelet Adhesiveness; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Whole Blood Coagulation Time | 1997 |
Inhibition of neointima formation after experimental coronary artery stenting: a new biodegradable stent coating releasing hirudin and the prostacyclin analogue iloprost.
Topics: Absorbable Implants; Animals; Antithrombins; Coronary Disease; Coronary Vessels; Drug Delivery Systems; Hirudins; Iloprost; Lactic Acid; Polyesters; Polymers; Recurrence; Sheep; Stents; Swine; Tunica Intima | 2000 |
Antithrombogenic modification of small-diameter microfibrous vascular grafts.
Topics: Animals; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; Coated Materials, Biocompatible; Elastic Modulus; Endothelial Cells; Female; Fibrinolytic Agents; Graft Occlusion, Vascular; Hirudins; Humans; Lactic Acid; Materials Testing; Platelet Adhesiveness; Platelet Aggregation; Polyesters; Polyethylene Glycols; Polymers; Prosthesis Design; Rats; Rats, Sprague-Dawley; Thrombin; Thrombosis; Time Factors; Vascular Patency | 2010 |
Poly(lactic-co-glycolic) acid microspheres encapsulated in Pluronic F-127 prolong hirudin delivery and improve functional recovery from a demyelination lesion.
Topics: Animals; Antithrombins; Delayed-Action Preparations; Demyelinating Diseases; Fibrinolytic Agents; Heparin; Hirudin Therapy; Hirudins; Lactic Acid; Mice; Microspheres; Poloxamer; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Recovery of Function; Spinal Cord; Spinal Cord Injuries | 2014 |